ENTRADA THERAPEUTICS INC (TRDA) Stock Income Statement
USA - NASDAQ:TRDA - US29384C1080 - Common Stock
8.47 USD
-0.28 (-3.2%)
8.47 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 79.48M | 210.78M | 129.01M | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 175.00M | 164.00M | 132.00M | 97.25M | 51.13M | |||
| Research and Development | 134.61M | 125.31M | 99.88M | 66.61M | 35.93M | |||
| Selling, General, and Administrative Expenses | 40.83M | 38.00M | 32.00M | 30.64M | 15.20M | |||
| Operating Income | -96.87M | 47.00M | -3.16M | -97.25M | -51.13M | |||
| Interest Income/Expense | 19.26M | 19.47M | 15.22M | 2.63M | -30.00K | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -76.74M | 66.00M | 12.00M | -94.62M | -51.16M | |||
| Income Tax | -3.55M | 860.00K | 19.00M | null | null | |||
| Net Income | -72.87M | 66.00M | -6.69M | -94.62M | -51.16M | |||
| EBITDA | -92.96M | 50.77M | -320.00K | -95.35M | -50.01M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.7799999999999998 | 1.68 | -0.2 | -3.02 | -8.16 | |||
| Non GAAP EPS | -1.7799999999999998 | 1.9100000000000001 | -0.26 | -3.02 | null | |||
| Statistics | ||||||||
| Profit Margin | -91.69% | 31.31% | -5.19% | N/A | N/A | |||
| Operating Profit Margin | -121.89% | 22.30% | -2.45% | N/A | N/A | |||
All data in USD